Investors who lost money on Exscientia plc should contact Levi & Korsinsky about an ongoing investigation - EXAIAccesswire • 03/26/24
Levi & Korsinsky Reminds Exscientia plc Investors of the Ongoing Investigation into Potential Violations of Securities Laws - EXAIAccesswire • 03/25/24
EXAI ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Exscientia plcAccesswire • 03/22/24
Lost Money on Exscientia plc(EXAI)? Contact Levi & Korsinsky Regarding an Ongoing InvestigationAccesswire • 03/21/24
An Investigation Has Commenced on Behalf of Exscientia plc Shareholders. Contact Levi & Korsinsky to Discuss your EXAI Losses.Accesswire • 03/15/24
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Exscientia plc (EXAI)Accesswire • 03/12/24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Exscientia plc - EXAIPRNewsWire • 03/11/24
Levi & Korsinsky, LLP Investigates Possible Securities Fraud Violations by Exscientia plc (EXAI)Accesswire • 03/10/24
EXAI STOCK ALERT: Levi & Korsinsky Notifies Exscientia plc Investors of an Ongoing InvestigationAccesswire • 03/07/24
Levi & Korsinsky Reminds Shareholders of an Investigation into Exscientia plc (EXAI) Regarding Potential Securities Fraud AllegationsAccesswire • 03/07/24
EXAI ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Exscientia plcAccesswire • 03/06/24
Levi & Korsinsky Announces an Investigation on Behalf of Exscientia plc (EXAI) Shareholders Who May Have Been Affected by FraudAccesswire • 03/05/24
Exscientia plc (EXAI) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their RightsAccesswire • 03/03/24
Did Exscientia plc Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - EXAIAccesswire • 03/01/24
Exscientia plc (EXAI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsBusiness Wire • 02/26/24
Exscientia Initiates Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer PatientsBusiness Wire • 02/07/24
The Cutting Edge: 3 Stocks to Buy for the Next Generation of Biotech BreakthroughsInvestorPlace • 01/25/24